Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

Quigley, David A., Dang, Ha X., Zhao, Shuang G., Lloyd, Paul, Aggarwal, Rahul, Alumkal, Joshi J., Foye, Adam, Kothari, Vishal +55 more·2018·Cell

DOI 10.1016/j.cell.2018.06.039

Cited by (738)

Items 101–200 of 738

BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Dae‐Hwan Kim, Duanchen Sun, William K. Storck, Katherine Welker Leng, Chelsea Jenkins, Daniel J. Coleman, David Sampson, Xiangnan Guan, Anbarasu Kumaraswamy, Eva S. Rodansky et al. · 2021 · Clinical Cancer Research
Advances of Zinc Signaling Studies in Prostate Cancer
Dangdang Li, Daniel B. Stovall, Wenmeng Wang, Guangchao Sui · 2020 · International Journal of Molecular Sciences
CDK12 and PAK2 as novel therapeutic targets for human gastric cancer
Hui Liu, Seung Ho Shin, Hanyong Chen, Tingting Liu, Zhi Li, Yamei Hu, Fangfang Liu, Chengjuan Zhang, Doon Jun Kim, Kangdong Liu et al. · 2020 · Theranostics
Multiplexed functional genomic analysis of 5’ untranslated region mutations across the spectrum of prostate cancer
Yiting Lim, Sonali Arora, Samantha L. Schuster, Lukas Corey, Matthew Fitzgibbon, Cynthia L. Wladyka, Xiaoying Wu, Ilsa M. Coleman, Jeffrey J. Delrow, Eva Corey et al. · 2021 · Nature Communications
Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer
Stanley Zhou, James R. Hawley, Fraser Soares, Giacomo Grillo, Mona Teng, Seyed Ali Madani Tonekaboni, Junjie Tony Hua, Ken J. Kron, Parisa Mazrooei, Musaddeque Ahmed et al. · 2020 · Nature Communications
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang George Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha, Arian Lundberg, Cameron Herberts, Adam Foye, Rahul Raj Aggarwal et al. · 2022 · Cancer Research
Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer
Anbarasu Kumaraswamy, Katherine Welker Leng, Thomas Christopher Westbrook, Joel A. Yates, Shuang George Zhao, Christopher P. Evans, Felix Yi-Chung Feng, Todd Matthew Morgan, Joshi J. Alumkal · 2021 · European Urology
Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy
Fabrizio Fontana, Martina Anselmi, Patrízia Limonta · 2022 · Cancer Letters
Androgen receptor mutations for precision medicine in prostate cancer
Masaki Shiota, Shusuke Akamatsu, Shigehiro Tsukahara, Shohei Nagakawa, Takashi Matsumoto, Masatoshi Eto · 2022 · Endocrine Related Cancer
Precise characterization of somatic complex structural variations from tumor/control paired long-read sequencing data with nanomonsv
Yuichi Shiraishi, Junji Koya, Kenichi Chiba, Ai Okada, Yasuhito Arai, Yuki Saito, Tatsuhiro Shibata, Keisuke Kataoka · 2023 · Nucleic Acids Research
Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer
Kevin Gonthier, Raghavendra Tejo Karthik Poluri, Étienne Audet‐Walsh · 2019 · The Journal of Steroid Biochemistry and Molecular Biology
Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance
Ruchi Ghildiyal, Mithila Sawant, Arun Renganathan, Kiran N. Mahajan, Eric H. Kim, Jingqin Luo, Ha X. Dang, Christopher A. Maher, Felix Yi-Chung Feng, Nupam P. Mahajan · 2021 · Cancer Research
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation
Gian Marco Franceschini, Orsetta Quaini, Kei Mizuno, Francesco Orlando, Yari Ciani, Sheng‐Yu Ku, Michael Sigouros, Emily C. Rothmann, Alicia Alonso, Matteo Benelli et al. · 2023 · Cancer Discovery
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
Jonathan Chou, Emily A. Egusa, Sinan Wang, Michelle L. Badura, Fei Lee, Anil P. Bidkar, Jun Zhu, Tanushree Shenoy, Kai R. Trepka, Troy M. Robinson et al. · 2022 · Cancer Research
Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases
Giacomo Canesin, Annalisa Di Ruscio, Mailin Li, Simone Ummarino, Andreas Hedblom, Reeham Choudhury, Agnieszka Krzyzanowska, Eva Csizmadia, Macarena Palominos, Anna Stiehm et al. · 2020 · Cell Reports
Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer
Sinja Taavitsainen, Matti Annala, Elisa Marie Ledet, Kevin Beja, Patrick J. Miller, Marcus W. Moses, Matti Nykter, Kim N. Chi, Oliver A. Sartor, Alexander William Wyatt · 2019 · JCO Precision Oncology
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
Miguel González Vélez, Heidi Kosiorek, Jan B. Egan, Andrea L. McNatty, Irbaz Bin Riaz, Steven Ray Hwang, Glenn A. Stewart, Thai H. Ho, Cassandra N. Moore, Parminder Pal Singh et al. · 2021 · Prostate Cancer and Prostatic Diseases
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types
William S. Chen, Mohammed Alshalalfa, Shuang George Zhao, Yang Liu, Brandon Arvin Virgil Mahal, David Alan Quigley, Ting Wei, Elai Davicioni, Timothy Richard Rebbeck, Philip W. Kantoff et al. · 2019 · Clinical Cancer Research
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer
Jamie M. Sperger, Hamid Emamekhoo, Rana R. McKay, Charlotte N. Stahlfeld, Anupama Singh, Xinyi E. Chen, Lucia Kwak, Cole S. Gilsdorf, Serena K. Wolfe, Xiao X. Wei et al. · 2021 · Journal of Clinical Oncology
STEAP1–4 (Six-Transmembrane Epithelial Antigen of the Prostate 1–4) and Their Clinical Implications for Prostate Cancer
Xu, Michael, Evans, Latese, Bizzaro, Candice L., Quaglia, Fabio, Verrillo, Cecilia E., Li, Li, Stieglmaier, Julia, Schiewer, Matthew J., Languino, Lucia R., Kelly, William K. · 2022 · Cancers
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors
Sujun Chen, Jessica Petricca, Wenbin Ye, Jiansheng Guan, Yong Zeng, Nicholas Cheng, Linsey Gong, Shu Yi Shen, Junjie Tony Hua, Megan Crumbaker et al. · 2022 · Nature Communications
Androgen receptor-binding sites are highly mutated in prostate cancer
Tunç Morova, Daniel R. McNeill, Nada Lallous, Mehmet Gönen, Kush Dalal, David M. Wilson, Attila Gürsoy, Özlem Keskin, Nathan A. Lack · 2020 · Nature Communications
Comprehensive analysis of metastatic gastric cancer tumour cells using single-cell RNA-seq
Bin Wang, Yingyi Zhang, Tao Qing, Kaichen Xing, Jie Li, Timing Zhen, Sibo Zhu, Xianbao Zhan · 2021 · Scientific Reports
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer
Yasutaka Yamada, Varadha Balaji Venkadakrishnan, Kei Mizuno, Martin K. Bakht, Sheng‐Yu Ku, Maria Mica Garcia, Himisha Beltran · 2023 · Science Translational Medicine
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity
Thomas Christopher Westbrook, Xiangnan Guan, Eva S. Rodansky, Diana Lisbeth Flores, Chia-Jen Liu, Aaron M. Udager, Radhika A. Patel, Michael C. Haffner, Ya‐Mei Hu, Duanchen Sun et al. · 2022 · Nature Communications
iRGD‐Liposomes Enhance Tumor Delivery and Therapeutic Efficacy of Antisense Oligonucleotide Drugs against Primary Prostate Cancer and Bone Metastasis
Jibin Guan, Hong Guo, Tang Tang, Yihan Wang, Yushuang Wei, Punit P. Seth, Yingming Li, Scott M. Dehm, Erkki I. Ruoslahti, Hong‐Bo Pang · 2021 · Advanced Functional Materials
The landscape of RNA polymerase II–associated chromatin interactions in prostate cancer
Susmita Gurjar Ramanand, Yong Chen, Jiapei Yuan, Kelly Daescu, Maryou B.K. Lambros, Kathleen E. Houlahan, Suzanne Carreira, Wei Yuan, GuemHee Baek, Adam Sharp et al. · 2020 · Journal of Clinical Investigation
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis
Josef Leibold, Marcus A. Ruscetti, Zhen Cao, Yu-Jui Ho, Timour Baslan, Min Zou, Wassim M. Abida, Judith Feucht, Teng Han, Francisco M. Barriga et al. · 2020 · Cancer Discovery
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Raj Aggarwal, Nicholas Robert Rydzewski, Li Zhang, Adam Foye, Won Kyum Kim, Kyle T. Helzer, Hamza Bakhtiar, Sei‐Won Laura Chang, Marc D. Perry, Martin Edwin Gleave et al. · 2021 · JAMA Oncology
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer
Lisa N. Chesner, Fanny Polesso, Julie Nicole Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg, Rajdeep Das, Tanushree Shenoy, Martin Sjöström, Faming Zhao et al. · 2024 · Cancer Discovery
A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling
Jianong Zhang, Jiangbo Wei, Rui Sun, Haoyue Sheng, Kai Yin, Yunqian Pan, Rafael E. Jiménez, Sujun Chen, Xiaolong Cui, Zhongyu Zou et al. · 2023 · Molecular Cell
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
Jamie M. Sperger, Kyle T. Helzer, Charlotte N. Stahlfeld, Dawei Jiang, Anupama Singh, Katherine R. Kaufmann, David J. Niles, Erika Héninger, Nicholas Robert Rydzewski, Liguo Wang et al. · 2023 · Clinical Cancer Research
Genomic Profiling of Prostate Cancer: An Updated Review
Koji Hatano, Norio Nonomura · 2021 · The World Journal of Men s Health
Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker
Filip Ionescu, Jingsong Zhang, Liang Wang · 2022 · Cancers
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype
Heidi Fettke, Chao Dai, Edmond M. Kwan, Tiantian Zheng, Pan Du, Nicole Ng, Patricia E. Bukczynska, Maria M. Docanto, Louise Kathleen Kostos, Siavash Foroughi et al. · 2023 · EBioMedicine
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
Thomas P. Burris, Ian Mitchelle S. de Vera, Isabelle Côté, Colin A. Flaveny, Udayanga S. Wanninayake, Arindam Chatterjee, John K. Walker, Nickolas Steinauer, Jinsong Zhang, Laurel A. Coons et al. · 2023 · Pharmacological Reviews
Targeting the androgen receptor and overcoming resistance in prostate cancer
David Johnson Einstein, Seiji Arai, Steven P. Balk · 2019 · Current Opinion in Oncology
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling
Disharee Nath, Xiang Li, Claudia Mondragon, Dawn E. Post, Ming Chen, Julie R. White, Anita Hryniewicz‐Jankowska, Tiffany N. Caza, Vladimir A. Kuznetsov, Heidi Hehnly et al. · 2019 · Cell Communication and Signaling
Large tandem duplications affect gene expression, 3D organization, and plant–pathogen response
Ariadna Picart-Picolo, Stefan Grob, Nathalie Picault, Michal Franek, Christel Llauro, Thierry Halter, Tom R. Maier, Edouard Jobet, Julie Descombin, Panpan Zhang et al. · 2020 · Genome Research
Regulation of AR mRNA translation in response to acute AR pathway inhibition
Syam Prakash Somasekharan, Neetu Saxena, Fan Zhang, Eliana Beraldi, Jia Ni Huang, Christina Gentle, Ladan Fazli, Marisa Thi, Poul H. B. Sorensen, Martin Edwin Gleave · 2021 · Nucleic Acids Research
From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer
Ekaterina Nevedomskaya, Bernard Haendler · 2022 · International Journal of Molecular Sciences
Advances in single-cell long-read sequencing technologies
Pallavi Gupta, Hannah O’Neill, Ernst Jurgen Wolvetang, Aniruddha Chatterjee, Ishaan Gupta · 2024 · NAR Genomics and Bioinformatics
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells
Rachid Safi, Suzanne E. Wardell, Paige Watkinson, Xiaodi Qin, Marissa Lee, Sunghee Park, Taylor Krebs, Emma L. Dolan, Adam Blattler, Toshiya Tsuji et al. · 2024 · Nature Communications
Future directions for precision oncology in prostate cancer
Kei Mizuno, Himisha Beltran · 2022 · The Prostate
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies
Jinshou Yang, Feihan Zhou, Xiyuan Luo, Yuan Fang, Xing Wang, Xiaohong Liu, Ruiling Xiao, Decheng Jiang, Yuemeng Tang, Gang Yang et al. · 2025 · Cell Death Discovery
WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth
Keshan Wang, Fen Ma, Seiji Arai, Yun Wang, Andreas S. Varkaris, Larysa Poluben, Olga S. Voznesensky, Fang Xie, Xiaoping Zhang, Xin Yuan et al. · 2023 · Cancer Research
Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression
Tingting Zhang, Faming Zhao, Yahang Lin, Mingsheng Liu, Hongqing Zhou, Fengzhen Cui, Yang Jin, Liang Chen, Xia Sheng · 2024 · Theranostics
Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial
Edmond M. Kwan, Sarah W.S. Ng, Sofie H. Tolmeijer, Louise Emmett, Shahneen Kaur Sandhu, James Patrick Buteau, Amir Iravani, Anthony Michael Joshua, Roslyn J. Francis, Vinod Vijay Subhash et al. · 2025 · Nature Medicine
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
David T. Pointer, David Roife, Benjamin Daniel Powers, Gilbert Zvikomborero Murimwa, Sameh Elessawy, Zachary Thompson, Michael J. Schell, Pamela Joy Hodul, José M. Pimiento, Jason B. Fleming et al. · 2020 · BMC Cancer
Therapeutic potential of p53 reactivation in prostate cancer: Strategies and opportunities
Sangeeta Kumari, Vikas Sharma, Rahul Tiwari, Jay Prakash Maurya, Bharat Bhusan Subudhi, Dhirodatta Senapati · 2022 · European Journal of Pharmacology
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer
Shuang G. Zhao, M. Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg, C. Pan, C. Arlidge, James R. Hawley, A. Foye et al. · 2024 · Nature Genetics
Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis
Wenjun Wang, Lingyu Li, Jiuwei Cui · 2020 · Epigenetics & Chromatin
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches
Mark P. Labrecque, Joshi J. Alumkal, Ilsa M. Coleman, Peter S. Nelson, Colm M. Morrissey · 2021 · Endocrine Related Cancer
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer
Stephen Tang, Vidyalakshmi Sethunath, Nebiyou Y. Metaferia, Marina F. Nogueira, Daniel S. Gallant, Emma R. Garner, Lauren A. Lairson, Christopher M. Penney, Jiao Li, Maya K. Gelbard et al. · 2022 · Cell Reports
CDK12: cellular functions and therapeutic potential of versatile player in cancer
Květa Pilařová, Jan Herudek, Dalibor Blažek · 2020 · NAR Cancer
The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
Manling Huang, Minghui He, Yu Guo, Heping Li, Shunli Shen, Yubin Xie, Xiaoxing Li, Han Xiao, Lujing Fang, Dongming Li et al. · 2020 · Clinical Cancer Research
Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
Daisuke Obinata, Mitchell G. Lawrence, Ken‐ichi Takayama, Nicholas Choo, Gail Petuna Risbridger, Satoru Takahashi, Satoshi Inoue · 2020 · Frontiers in Oncology
Plasma Cell–Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate Cancer
Edmond M. Kwan, Chao Dai, Heidi Fettke, Christine Hauser, Maria M. Docanto, Patricia E. Bukczynska, Nicole Ng, Siavash Foroughi, Lisa-Jane K. Graham, Kate Lynette Mahon et al. · 2021 · JCO Precision Oncology
Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer
Maibritt Nørgaard, Marianne Trier Bjerre, Jacob Fredsøe, Søren Vang, Jørgen Bjerggaard Jensen, Bram De Laere, Henrik Grönberg, Michael Borre, Johan Lindberg, Karina Dalsgaard Sørensen · 2023 · Clinical Chemistry
Prostate organoids: emerging experimental tools for translational research
Michael L. Beshiri, Supreet Agarwal, Juan Juan Yin, Kathleen Kelly · 2023 · Journal of Clinical Investigation
Beyond Kinases: Targeting Replication Stress Proteins in Cancer Therapy
Katherine E. Baillie, Peter C. Stirling · 2020 · Trends in cancer
Chromothripsis as a pathogenic driver of multiple myeloma
Francesco Maura, Eileen Mary Boyle, Even Holth Rustad, Cody Ashby, David Kaminetzky, Benedetto Bruno, Marc Justin Braunstein, Michael Bauer, Patrick Blaney, Yubao Wang et al. · 2021 · Seminars in Cell and Developmental Biology
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition
Wanting Han, Mingyu Liu, Dong Gwan Han, Muqing Li, Anthia A. Toure, Zifeng Wang, Anna Besschetnova, Susan C. Patalano, Jill A. Macoska, Shuai Gao et al. · 2022 · Oncogene
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
Azra Ajkunic, Erolcan Sayar, Martine P. Roudier, Radhika A. Patel, Ilsa M. Coleman, Navonil De Sarkar, Brian P. Hanratty, Mohamed Adil, Jimmy L. Zhao, Samir Zaidi et al. · 2024 · npj Precision Oncology
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
Caihong Li, Dongkai Cheng, Peng Li · 2025 · Frontiers in Oncology
Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation
Simon J. Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, Richard Newman, Dominik Mumberg, Bernard Haendler · 2020 · Molecular Oncology
Use of Circulating Tumor DNA for the Clinical Management of Metastatic Castration-Resistant Prostate Cancer: A Multicenter, Real-World Study
Baijun Dong, Liancheng Fan, Bin Yang, Wei Chen, Yonghong Li, Kaijie Wu, Fengbo Zhang, Haiying Dong, Huihua Cheng, Jiahua Pan et al. · 2021 · Journal of the National Comprehensive Cancer Network
Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer
Fen Ma, Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben, Zhongkai Gu, Joshua W. Russo, David Johnson Einstein, Huihui Ye et al. · 2022 · Cancer Research
Plant Bioactives and the Prevention of Prostate Cancer: Evidence from Human Studies
Tracey L. Livingstone, Gemma Beasy, Robert Mills, Jenny A. Plumb, Paul W. Needs, Richard F. Mithen, Μαρία Τράκα · 2019 · Nutrients
Prostate cancer research: The next generation; report from the 2019 Coffey‐Holden Prostate Cancer Academy Meeting
Andrea K. Miyahira, Adam Sharp, Leigh Ellis, Jennifer Clare Jones, Salma Kaochar, H. Benjamin Larman, David Alan Quigley, Huihui Ye, Jonathan W. Simons, Kenneth J. Pienta et al. · 2019 · The Prostate
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer
Joseph D. Schonhoft, Jimmy L. Zhao, Adam Jendrisak, Emily A. Carbone, Ethan S. Barnett, Melanie A. Hullings, Audrey Gill, Ramsay Sutton, Jerry S. H. Lee, Angel Ernesto Dago et al. · 2020 · Cancer Research
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review
Kim Van der Eecken, Jan Pieter Vanwelkenhuyzen, Matthew Pierre Deek, Phuoc Tho Tran, Evan W. Warner, Alexander William Wyatt, Edmond M. Kwan, Sofie Verbeke, Jo Van Dorpe, Valérie Fonteyne et al. · 2021 · European Urology Oncology
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
Das, Rajdeep, Sjöström, Martin, Shrestha, Raunak, Yogodzinski, Christopher, Egusa, Emily A., Chesner, Lisa N., Chen, William S., Chou, Jonathan, Dang, Donna K., Swinderman, Jason T. et al. · 2021 · Nature Communications
PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathway
Chengcheng Lv, Shui Fu, Qingzhuo Dong, Zi Yu, Gejun Zhang, Chuize Kong, Cheng Fu, Yu Zeng · 2019 · Journal of Experimental & Clinical Cancer Research
Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor
Elin Thysell, Linda Vidman, Erik Bovinder Ylitalo, Emma Jernberg, Sead Crnalic, Diego Iglesias‐Gato, Amilcar Flores‐Morales, Pär E. Stattin, Lars Egevad, Anders Widmark et al. · 2019 · Molecular Oncology
Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation
Edmond M. Kwan, Alexander William Wyatt, Kim N. Chi · 2022 · Frontiers in Oncology
Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target
Guoqiang Liu, Minggang Zhu, Mingrui Zhang, Feng Pan · 2023 · Cancers
Reliable interpretability of biology-inspired deep neural networks
2023
Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications
Matthew J. Ryan, Rohit Bose · 2019 · Frontiers in Oncology
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
David González de Castro, Joaquı́n Mateo, Albrecht Stenzinger, Federico Rojo, Michelle Shiller, Alexander William Wyatt, Frederique Madeleine Penault-Llorca, Leonard G. Gomella, Rosalind A. Eeles, Anders S Bjartell · 2021 · The Journal of Pathology Clinical Research
Functional mapping of androgen receptor enhancer activity
Chia-Chi Flora Huang, Shreyas Lingadahalli, Tunç Morova, Doğancan Özturan, Eugene Hu, Ivan Pak Lok Yu, Simon Linder, Marlous Hoogstraat, Suzan Stelloo, Funda Sar et al. · 2021 · Genome biology
Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
Haozhe Zhang, Zhou Yi, Zengzhen Xing, Rajiv Kumar Sah, Junqi Hu, Hailiang Hu · 2022 · International Journal of Molecular Sciences
Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries
Daisuke Obinata, Ken‐ichi Takayama, Satoshi Inoue, Satoru Takahashi · 2024 · International Journal of Urology
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, Claire Lugnier, Christian Heßlinger, Peter Nickolaus, David A. Kass, Walma Pereira de Vasconcelos, Rodolphe Fischmeister, Stefan Brocke et al. · 2025 · Pharmacological Reviews
Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer
Nicholas Mitsiades, Salma Kaochar · 2021 · Endocrine Related Cancer
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
Erik Bovinder Ylitalo, Elin Thysell, Mattias Landfors, Maria Brattsand, Emma Jernberg, Sead Crnalic, Anders Widmark, Magnus Hultdin, Anders R. J. Bergh, Sofie Degerman et al. · 2021 · Clinical Epigenetics
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer
Navonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, Ilsa M. Coleman, Gavin Ha, Lisa S. Ang, Emily A. Kohlbrenner, Sander B. Frank, Talina A. Nunez, Stephen J. Salipante et al. · 2021 · JCI Insight
Nurturing the marriages of urinary liquid biopsies and nano‐diagnostics for precision urinalysis of prostate cancer
Caizhi Liao, Zhihao Wu, Chan Lin, Xiaofeng Chen, Yaqun Zou, Zhao Wan, Xin Li, Guangqi Huang, Baisheng Xu, Giovanni E. Briganti et al. · 2023 · Smart Medicine
A case report of multiple primary prostate tumors with differential drug sensitivity
Scott C. Wilkinson, Stephanie A. Harmon, Nicholas Taylor Terrigino, Fatima H. Karzai, Peter A. Pinto, Ravi Amrit Madan, David James VanderWeele, Ross G. Lake, Rayann Atway, John R. Bright et al. · 2020 · Nature Communications
Androgen receptor variants: RNA-based mechanisms and therapeutic targets
Kiel T. Tietz, Scott M. Dehm · 2020 · Human Molecular Genetics
ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers
Eric H. Kim, Dengfeng Cao, Nupam P. Mahajan, Gerald L. Andriole, Kiran N. Mahajan · 2020 · NAR Cancer
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Ivan de Kouchkovsky, Arpit Rao, Benedito A. Carneiro, Li Zhang, Catriona Lewis, Audrey Phone, Eric J. Small, Terence W. Friedlander, Lawrence H. Fong, Pamela L. Paris et al. · 2022 · Clinical Cancer Research
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
Preston D. Crowell, Jenna M. Giafaglione, Anthony E. Jones, Nicholas M. Nunley, Takao Hashimoto, Amelie M.L. Delcourt, Anton Petcherski, Raag Agrawal, Matthew J. Bernard, Johnny A. Diaz et al. · 2023 · Cell Reports
Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers
Suzan Stelloo, Andries Marinus Bergman, Wilbert T. Zwart · 2019 · Endocrine Related Cancer
Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
Shiv Verma, Kumari Sunita Prajapati, Prem Prakash Kushwaha, Mohd Shuaib, Atul Kumar Singh, Shashank Kumar, Sanjay Gupta · 2020 · Cancer Drug Resistance
The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration‐resistant prostate cancer in real‐world clinical practice: The multi‐institutional observational ZENSHIN study
Hiroji Uemura, Mototsugu Oya, Toshiyuki Kamoto, Mikio Sugimoto, Kenta Shinozaki, Kiyomi Morita, Ryo Koto, Mai Takahashi, Masahiro Nii, Eisei Shin et al. · 2022 · Cancer Medicine
Genome-guided discovery of cancer therapeutic targets
Prathyusha Konda, Simon Garinet, Eliezer M. Van Allen, Srinivas Raghavan Viswanathan · 2023 · Cell Reports
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression
Raunak Shrestha, Lisa N. Chesner, Meng Zhang, Stanley Zhou, Adam Foye, Arian Lundberg, Alana S. Weinstein, Martin Sjöström, Xiaolin Zhu, Thaidy Moreno-Rodriguez et al. · 2024 · Cancer Research
Chromothripsis in Human Breast Cancer
Michiel Bolkestein, John Wong, Verena Thewes, Verena Körber, Mario Hlevnjak, Shaymaa Elgaafary, Markus Schulze, Felix K. F. Kommoss, Hans‐Peter Sinn, Tobias Anzeneder et al. · 2020 · Cancer Research
Distinct Genomic Alterations in Prostate Tumors Derived from African American Men
Wennuan Liu, S. Lilly Zheng, Rong Na, Lin Wei, Jishan Sun, Johnie Gallagher, Jun Wei, William Kyle Resurreccion, Sarah Ernst, Karen Sandell Sfanos et al. · 2020 · Molecular Cancer Research